Citadel Advisors LLC 13D and 13G filings for Bolt Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:19 pm Sale | 2024-09-30 | 13G | Bolt Biotherapeutics, Inc. BOLT | Citadel Advisors LLC | 0 0.000% | -2,458,958 (Position Closed) | Filing |
| 2024-02-14 4:57 pm Sale | 2023-12-31 | 13G | Bolt Biotherapeutics, Inc. BOLT | Citadel Advisors LLC | 2,458,958 6.500% | -293,237 (-10.65%) | Filing |
| 2023-02-14 08:02 am Sale | 2022-12-31 | 13G | Bolt Biotherapeutics, Inc. BOLT | Citadel Advisors LLC | 2,752,195 7.300% | -60,254 (-2.14%) | Filing |
| 2022-02-14 06:12 am Sale | 2021-12-31 | 13G | Bolt Biotherapeutics, Inc. BOLT | Citadel Advisors LLC | 2,812,449 7.500% | -129,558 (-4.40%) | Filing |
| 2021-02-19 4:03 pm Purchase | 2021-02-09 | 13G | Bolt Biotherapeutics, Inc. BOLT | Citadel Advisors LLC | 2,942,007 8.100% | 2,942,007 (New Position) | Filing |